trans-AUCB

CAS No. 885012-33-9

trans-AUCB ( t-AUCB )

Catalog No. M24903 CAS No. 885012-33-9

trans-AUCB is an effective and selective soluble epoxide hydrolase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 57 In Stock
5MG 87 In Stock
10MG 147 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    trans-AUCB
  • Note
    Research use only, not for human use.
  • Brief Description
    trans-AUCB is an effective and selective soluble epoxide hydrolase inhibitor.
  • Description
    trans-AUCB is an effective and selective soluble epoxide hydrolase inhibitor (IC50s: 1.3 nM, 8 nM, 8 nM for hsEH, mouse sEH and rat sEH, respectively).
  • Synonyms
    t-AUCB
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    sEH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    885012-33-9
  • Formula Weight
    412.5
  • Molecular Formula
    C24H32N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (242.41 mM; Need ultrasonic)
  • SMILES
    O=C(O)C1=CC=C(O[C@H]2CC[C@H](NC(NC34CC5CC(C4)CC(C5)C3)=O)CC2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li J, et al. t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activatingNF-κB-p65. J Neurooncol. 2012 Jul;108(3):385-93.
molnova catalog
related products
  • Allicin

    Allicin exerts antioxidant, bactericidal, anti-cancer, anti-inflammatory activities, it exerts an inhibitory immunomodulatory effect on intestinal epithelial cells.

  • Hyaluronic acid

    Hyaluronic Acid is a glucosaminoglycan consisting of D-glucuronic acid and N-acetyl-D-glucosamine disaccharide units.

  • NAV-2729

    NAV-2729 inhibits six ArfGEFs (human ARNO, EFA6, BIG1, and BRAG2 and Legionella and Rickettsia RalF), the strongest effects being against BRAG2, Arf1 and Arf6.